In addition, Ki67 and cleaved-caspase 3 (C-C3) staining indicated that trametinib treatment decreases proliferation and induces apoptosis in c-MET/sgp53 HCC cell xenografts (Fig. 7). The gene discussed is CASP3; the disease is hepatocellular carcinoma.